Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 12 - Chas Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chas Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chas Schultz Today - Breaking & Trending Today
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021
Replay International Dial-in Number: (404) 537-3406 Conference ID: 3687855 The dial-in replay will be available for 14 days following the call. An audio webcast will be available online at www.lexpharma.com/events, with a webcast replay accessible for 14 days after the call. About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through its Genome5000™ program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic p...
Source: marketscreener.com
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in ... Lexicon Pharmaceuticals, Inc.December 31, 2020 GMT THE WOODLANDS, Texas, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today the commencement of patient dosing in RELIEF-PHN 1, a Phase 2 randomized, placebo-controlled, multi-center clinical study of LX9211 for the treatment of post-herpetic neuralgia. LX9211 is a potent oral small molecule inhibitor of adapt...
Source: apnews.com